Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS)

CUSIP: H5870P102

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 6 signals
Share change
+1,783
SEC-reported price per share
$12.33
Number of holders
9
Value change
+$147,595
Number of buys
3
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,900,797

Security key

H5870P102

Report period

Q2 2023

Institutions

9

Top holders

9

Ownership snapshot

Top reported holders of OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pivotal bioVenture Partne...
Disclosed value leader
Pivotal bioVenture Partne...
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F Highest disclosed value: $17,692,286 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Pivotal bioVenture Partners Investment Advisor LLC has the largest disclosed position value at $17.69M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pivotal bioVenture Partners Investment Advisor LLC's linked filing trail.
Disclosed position value Top 5
Pivotal bioVenture Partners Inves... $17.69M
Nan Fung Group Holdings Ltd $4.84M
Lombard Odier SCmA Compagnie $471.9K
HRT FINANCIAL LP $186K
Tyrus Capital S.A.M. $54.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
13F
—
denominator unverified
$17,692,286
2,381,196 shares
— 31 Mar 2023
Nan Fung Group Holdings Ltd
13F
Company
13F
—
denominator unverified
$4,837,673
651,100 shares
— 31 Mar 2023
Lombard Odier SCmA Compagnie
13F
Individual
13F
—
denominator unverified
$471,900
65,000 shares
— 31 Mar 2023
HRT FINANCIAL LP
13F
Company
13F
—
mixed-class rows
$186,000
49,678 shares
mixed-class rows
— 31 Mar 2023
Tyrus Capital S.A.M.
13F
Company
13F
—
denominator unverified
$54,899
133,332 shares
— 31 Mar 2023
NOMURA HOLDINGS INC
13F
Company
13F
—
denominator unverified
$50,400
126,000 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
9
Shares
3,125,204
Rows available
9
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2026 Across Filers

Q1 2026 holders
57
Q2 2023 holders
9
Holder diff
-48
Investor Q1 2026 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2026 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .